These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 15823107)
1. A novel early-stage orthotopic model for ovarian cancer in the Fischer 344 rat. Sloan Stakleff KD; Rouse AG; Ryan AP; Haller NA; Von Gruenigen VE Int J Gynecol Cancer; 2005; 15(2):246-54. PubMed ID: 15823107 [TBL] [Abstract][Full Text] [Related]
2. Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 rat. Rose GS; Tocco LM; Granger GA; DiSaia PJ; Hamilton TC; Santin AD; Hiserodt JC Am J Obstet Gynecol; 1996 Sep; 175(3 Pt 1):593-9. PubMed ID: 8828419 [TBL] [Abstract][Full Text] [Related]
3. Dissemination of intraperitoneal ovarian cancer: Discussion of mechanisms and demonstration of lymphatic spreading in ovarian cancer model. Feki A; Berardi P; Bellingan G; Major A; Krause KH; Petignat P; Zehra R; Pervaiz S; Irminger-Finger I Crit Rev Oncol Hematol; 2009 Oct; 72(1):1-9. PubMed ID: 19179094 [TBL] [Abstract][Full Text] [Related]
4. In vivo detection of metastatic ovarian cancer by means of 5-aminolevulinic acid-induced fluorescence in a rat model. Hornung R; Major AL; McHale M; Liaw LH; Sabiniano LA; Tromberg BJ; Berns MW; Tadir Y J Am Assoc Gynecol Laparosc; 1998 May; 5(2):141-8. PubMed ID: 9564061 [TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal photodynamic therapy for an ovarian cancer ascite model in Fischer 344 rat using hematoporphyrin monomethyl ether. Song K; Kong B; Li L; Yang Q; Wei Y; Qu X Cancer Sci; 2007 Dec; 98(12):1959-64. PubMed ID: 17900310 [TBL] [Abstract][Full Text] [Related]
6. Establishment of Fischer 344 rat model of ovarian cancer with lymphatic metastasis. Fan L; Liu Y; Zhang X; Kang Y; Xu C Arch Gynecol Obstet; 2014 Jan; 289(1):149-54. PubMed ID: 23828445 [TBL] [Abstract][Full Text] [Related]
7. Human embryonic stem cells--a potential vaccine for ovarian cancer. Zhang ZJ; Chen XH; Chang XH; Ye X; Li Y; Cui H Asian Pac J Cancer Prev; 2012; 13(9):4295-300. PubMed ID: 23167331 [TBL] [Abstract][Full Text] [Related]
8. [Study of the therapeutic effects of costimulatory molecules B7-1 and interleukin 12 modified tumor cells vaccines on ovarian epithelial carcinoma through induction of anti-cancer immunity of the body]. Liang HM; Jiang J; Kong BH; Ma DX; Jiang S Zhonghua Fu Chan Ke Za Zhi; 2003 Jun; 38(6):354-8. PubMed ID: 12895379 [TBL] [Abstract][Full Text] [Related]
9. Laparoscopic photodynamic diagnosis of ovarian cancer peritoneal micro metastasis: an experimental study. Collinet P; Sabban F; Cosson M; Farine MO; Villet R; Vinatier D; Mordon S Photochem Photobiol; 2007; 83(3):647-51. PubMed ID: 17117888 [TBL] [Abstract][Full Text] [Related]
10. Suppression of ovarian cancer cell tumorigenicity and evasion of Cisplatin resistance using a truncated epidermal growth factor receptor in a rat model. Chan JK; Pham H; You XJ; Cloven NG; Burger RA; Rose GS; Van Nostrand K; Korc M; Disaia PJ; Fan H Cancer Res; 2005 Apr; 65(8):3243-8. PubMed ID: 15833856 [TBL] [Abstract][Full Text] [Related]
11. Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer. Shaw TJ; Senterman MK; Dawson K; Crane CA; Vanderhyden BC Mol Ther; 2004 Dec; 10(6):1032-42. PubMed ID: 15564135 [TBL] [Abstract][Full Text] [Related]
12. A clinically relevant orthotopic implantation nude mouse model of human epithelial ovarian cancer--based on consecutive observation. Yi XF; Yuan ST; Lu LJ; Ding J; Feng YJ Int J Gynecol Cancer; 2005; 15(5):850-5. PubMed ID: 16174235 [TBL] [Abstract][Full Text] [Related]
13. The impact of the ovarian microenvironment on the anti-tumor effect of SPARC on ovarian cancer. Greenaway JB; Koehler A; McCulloch CA; Petrik J; Brown TJ; Ringuette MJ Biochem Cell Biol; 2012 Feb; 90(1):96-107. PubMed ID: 22003835 [TBL] [Abstract][Full Text] [Related]
14. Vaccination with embryonic stem cells generates effective antitumor immunity against ovarian cancer. Zhang Z; Chen X; Chang X; Ye X; Li Y; Cui H Int J Mol Med; 2013 Jan; 31(1):147-53. PubMed ID: 23174760 [TBL] [Abstract][Full Text] [Related]
15. Highly selective targeting of ovarian cancer with the photosensitizer PEG-m-THPC in a rat model. Hornung R; Fehr MK; Monti-Frayne J; Krasieva TB; Tromberg BJ; Berns MW; Tadir Y Photochem Photobiol; 1999 Oct; 70(4):624-9. PubMed ID: 10546556 [TBL] [Abstract][Full Text] [Related]
16. In the hunt for therapeutic targets: mimicking the growth, metastasis, and stromal associations of early-stage lung cancer using a novel orthotopic animal model. Weiss ID; Ella E; Dominsky O; Smith Y; Abraham M; Wald H; Shlomai Z; Zamir G; Feigelson SW; Shezen E; Bar-Shai A; Alon R; Izhar U; Peled A; Shapira OM; Wald O J Thorac Oncol; 2015 Jan; 10(1):46-58. PubMed ID: 25654727 [TBL] [Abstract][Full Text] [Related]
17. In vivo fluorescence detection of ovarian cancer in the NuTu-19 epithelial ovarian cancer animal model using 5-aminolevulinic acid (ALA). Major AL; Rose GS; Chapman CF; Hiserodt JC; Tromberg BJ; Krasieva TB; Tadir Y; Haller U; DiSaia PJ; Berns MW Gynecol Oncol; 1997 Jul; 66(1):122-32. PubMed ID: 9234932 [TBL] [Abstract][Full Text] [Related]
18. Establishment of two ovarian cancer orthotopic xenograft mouse models for in vivo imaging: A comparative study. Guo J; Cai J; Zhang Y; Zhu Y; Yang P; Wang Z Int J Oncol; 2017 Oct; 51(4):1199-1208. PubMed ID: 28902355 [TBL] [Abstract][Full Text] [Related]
19. Orthotopic implantation of primary N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide-induced bladder cancer in bladder submucosa: an animal model for bladder cancer study. Ibrahiem EH; Nigam VN; Brailovsky CA; Madarnas P; Elhilali M Cancer Res; 1983 Feb; 43(2):617-22. PubMed ID: 6848183 [TBL] [Abstract][Full Text] [Related]
20. Incidence of subclinical metastasis in stage I and II ovarian carcinoma. Piver MS; Barlow JJ; Lele SB Obstet Gynecol; 1978 Jul; 52(1):100-4. PubMed ID: 683618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]